Skip to content
Which Biologic Does Medicare Cover? Explained Clearly

Which Biologic Does Medicare Cover? Explained Clearly

Dec 23, 2025

Oscar Tellez

Biologics Covered by Medicare Explained

Introduction

Patients and caregivers often ask, “Which biologic does Medicare cover?” The answer is not simple. Medicare treats biologic drugs and orthobiologic therapies very differently. While many FDA-approved biologic drugs for autoimmune conditions are covered, most orthobiologic therapies like platelet-rich plasma (PRP), stem cells, and hyaluronic acid injections are excluded from standard Medicare coverage.

This article breaks down which biologics are approved, which are not, and why these differences exist. For a broader overview, see our parent guide Medicare Coverage for Orthobiologics.

Understanding Biologics vs. Orthobiologics

To understand Medicare’s stance, it’s important to separate these two categories:

  • Biologic Drugs: Pharmaceutical agents derived from living cells. Examples include monoclonal antibodies, immune-modulating therapies, and injectable drugs used for autoimmune diseases. These drugs go through standardized FDA approval and clinical trials.

  • Orthobiologics: Biological materials used in orthopedic care, such as PRP, stem cells, and hyaluronic acid. These therapies rely on patient-derived or tissue-based preparations and are often labeled investigational by Medicare.

This distinction is at the heart of why coverage exists for some biologics but not for others.

Which Biologic Does Medicare Cover?

Medicare does cover FDA-approved biologic drugs, especially for autoimmune and inflammatory conditions. Examples include:

  • Tumor Necrosis Factor (TNF) Inhibitors such as adalimumab (Humira®) and etanercept (Enbrel®).

  • Interleukin (IL) Blockers such as tocilizumab or secukinumab for rheumatoid or psoriatic arthritis.

  • Other biologics approved for osteoporosis, multiple sclerosis, and related diseases.

Medicare Part B vs. Part D Coverage

  • Part B: Covers biologic drugs that are infused or injected in a physician’s office or outpatient setting. Example: infliximab given for rheumatoid arthritis.

  • Part D: Covers self-administered biologic prescriptions, typically filled at a pharmacy.

This is why seniors may see biologic drugs approved under Medicare while regenerative injections like PRP remain excluded.

Medicare Coverage for PRP

When it comes to Medicare coverage for PRP, the stance is clear: PRP is not covered for musculoskeletal conditions. CMS classifies PRP as investigational for:

  • Osteoarthritis (knee, hip, shoulder)

  • Tendon injuries (e.g., tennis elbow, Achilles tendinopathy)

  • Post-surgical healing

The only partial exception: PRP may be approved in limited cases for chronic, non-healing diabetic wounds under specialized clinical trial protocols. For orthopedic patients, however, coverage does not exist.

Medicare Coverage for Stem Cell Therapy

Medicare coverage for stem cell therapy is even more restrictive. Medicare excludes stem cell injections for arthritis, tendon injuries, or back pain. Coverage is limited to:

  • Hematopoietic stem cell transplants for oncology and certain blood disorders.

  • Immune-related conditions where FDA-approved protocols exist.

This means orthopedic stem cell therapy remains entirely self-pay. Our related blog Cost of Stem Cell Therapy Under Medicare explores what patients can expect to spend privately.

Medicare Coverage for Hyaluronic Acid Injections

The rules around Medicare coverage for hyaluronic acid injections are more nuanced:

  • Traditional Medicare sometimes approves HA injections for knee osteoarthritis, but coverage depends on local contractors.

  • Some Medicare Advantage plans may expand HA coverage, but patients often need to prove conservative treatments (like physical therapy or NSAIDs) failed first.

  • HA injections for joints other than the knee are usually denied.

For seniors dealing with knee pain, our side blog Medicare Coverage for Knee Treatments explains how different injections are handled.

Why Medicare Covers Some Biologics but Not Orthobiologics

The difference lies in evidence, regulation, and standardization:

  1. Biologic drugs undergo years of clinical trials, FDA review, and standard manufacturing processes. Medicare accepts them as safe and effective.

  2. Orthobiologics like PRP and stem cells are not standardized. Different clinics use different centrifuge systems, concentrations, and protocols, leading to variable outcomes.

  3. Evidence gap: While studies show promise, long-term randomized trials are limited.

  4. Cost control: Covering high-cost orthobiologic therapies without standardized outcomes could burden Medicare financially.

Out-of-Pocket Expectations for Patients

Since Medicare rarely covers orthobiologic injections, seniors should prepare for direct expenses. Typical ranges include:

  • PRP injections: $500–$2,000 per session.

  • Stem cell therapy: $3,000–$8,000.

  • Hyaluronic acid injections: $300–$800 (sometimes partially reimbursed).

Regional Cost Differences

  • Urban centers: Tend to have higher fees due to demand and overhead.

  • Academic hospitals: Sometimes offer lower-cost access as part of clinical studies.

  • Private practices: Wide variation depending on technology and physician expertise.

Families often need to budget carefully or consider whether orthobiologics are worth the expense compared with covered alternatives.

Patient Perspective: Managing Care Without Coverage

When Medicare does not pay, patients and caregivers often weigh options like:

  • Choosing covered biologic drugs for autoimmune-related arthritis.

  • Opting for traditional therapies (steroids, physical therapy) before paying out-of-pocket for orthobiologics.

  • Asking providers about clinical trials that might reduce costs.

  • Seeking transparent upfront pricing to avoid surprise bills.

These strategies help families make informed choices about balancing medical need with financial reality.

Future Outlook: Will Medicare Expand Coverage?

Will Medicare eventually cover orthobiologics? Possibly. Key factors include:

  • FDA approval of PRP or stem cell systems for arthritis or tendon repair.

  • Standardized preparation protocols that reduce variability in outcomes.

  • Large-scale trials proving long-term safety and cost savings.

  • CMS pilot programs testing whether PRP or HA can reduce reliance on joint replacement or opioids.

Advocacy groups continue to push for broader recognition of regenerative therapies, but coverage changes are unlikely until stronger evidence emerges.

FAQs About Medicare and Biologics

1. Which biologic does Medicare cover for arthritis?
Medicare covers biologic drugs like TNF inhibitors and IL blockers for autoimmune arthritis, but not PRP or stem cells.

2. Does Medicare cover PRP injections?
No, PRP is considered investigational for orthopedic conditions, with rare exceptions for diabetic wounds.

3. Does Medicare cover stem cell therapy for joint pain?
No, orthopedic stem cell injections are excluded. Only certain hematopoietic transplants are covered.

4. Does Medicare pay for hyaluronic acid injections?
Sometimes, but mainly for knee osteoarthritis and depending on local contractor policies.

5. Will Medicare Advantage plans help?
Some Medicare Advantage plans expand HA coverage, but PRP and stem cells remain excluded.

Conclusion

So, which biologic does Medicare cover? The answer is that biologic drugs for autoimmune conditions are covered, but orthobiologic therapies like PRP, stem cells, and most hyaluronic acid injections are not. Patients and families should understand these differences before making care decisions.

For further reading:

  • Medicare Coverage for Orthobiologics – parent blog with the full overview.

  • Medicare Coverage for Knee Treatments – side blog on HA and joint injections.

  • Cost of Stem Cell Therapy Under Medicare – detailed breakdown of financial implications.

About Me

I’m Oscar Tellez, I’ve spent the past 10 years working in regenerative medicine. My focus is on advancing safe, evidence-based applications of PRP, fat, bone marrow, birth tissues such as Wharton’s Jelly, exosomes, and cell factors.I share insights designed to help clinicians responsibly integrate regenerative care into their practice while staying compliant with FDA, FTC, and DEA guidelines.

You can connect with me directly on [Website], [LinkedIn] and [Facebook].

DISCLAIMER:
This content is for educational purposes only and is not intended as medical or legal advice. Regenerative medicine products and therapies are subject to FDA, FTC, and DEA regulations. Clinicians should verify compliance and consult with qualified professionals before offering these treatments.